These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 24403475)

  • 1. Effectiveness of FDG-PET in screening of synchronous cancer of other organs in patients with esophageal cancer.
    Miyazaki T; Sohda M; Higuchi T; Tanaka N; Suzuki S; Sakai M; Yokobori T; Nakajima M; Fukuchi M; Tsushima Y; Kato H; Kuwano H
    Anticancer Res; 2014 Jan; 34(1):283-7. PubMed ID: 24403475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limitations of FDG-PET and FDG-PET with computed tomography for detecting synchronous cancer in pharyngeal cancer.
    Suzuki H; Hasegawa Y; Terada A; Ogawa T; Hyodo I; Suzuki M; Nakashima T; Tamaki T; Nishio M
    Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1191-5. PubMed ID: 19015450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Impact of (18)F-FDG PET/CT on the therapeutic management in the initial staging of the esophageal cancer].
    Pifarré-Montaner P; Fernández-León A; de Juan R; del Ama-Salvador ME; Galán M; Gámez-Cenzano C; Sans M
    Rev Esp Med Nucl; 2009; 28(3):101-5. PubMed ID: 19558949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synchronous primary neoplasms detected on 18F-FDG PET in staging of patients with esophageal cancer.
    van Westreenen HL; Westerterp M; Jager PL; van Dullemen HM; Sloof GW; Comans EF; van Lanschot JJ; Wiggers T; Plukker JT
    J Nucl Med; 2005 Aug; 46(8):1321-5. PubMed ID: 16085589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limitation of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography (FDG-PET) to detect early synchronous primary cancers in patients with untreated head and neck squamous cell cancer.
    Hanamoto A; Takenaka Y; Shimosegawa E; Ymamamoto Y; Yoshii T; Nakahara S; Hatazawa J; Inohara H
    Ann Nucl Med; 2013 Dec; 27(10):880-5. PubMed ID: 23979967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of synchronous cancers by fluorodeoxyglucose positron emission tomography/computed tomography during primary staging workup for esophageal squamous cell carcinoma in Taiwan.
    Chen SH; Chan SC; Chao YK; Yen TC
    PLoS One; 2013; 8(11):e82812. PubMed ID: 24312435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (18)F-FDG PET-detected synchronous primary neoplasms in the staging of esophageal cancer: incidence, cost, and impact on management.
    Malik V; Johnston C; Donohoe C; Claxton Z; Lucey J; Ravi N; Reynolds JV
    Clin Nucl Med; 2012 Dec; 37(12):1152-8. PubMed ID: 23154472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma.
    Hyun SH; Choi JY; Shim YM; Kim K; Lee SJ; Cho YS; Lee JY; Lee KH; Kim BT
    Ann Surg Oncol; 2010 Jan; 17(1):115-22. PubMed ID: 19826877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of three synchronous primary tumors demonstrated by F-18 FDG PET.
    Mittra E; Vasanawala M; Niederkohr R; Rodriguez C; Segall G
    Clin Nucl Med; 2007 Aug; 32(8):666-7. PubMed ID: 17667450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of [18]-FDG PET/CT in the initial staging of head and neck cancers].
    Fakhry N; Barberet M; Lussato D; Mundler O; Giovanni A; Zanaret M
    Rev Laryngol Otol Rhinol (Bord); 2007; 128(1-2):3-9. PubMed ID: 17633658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorine-18 fluorodeoxyglucose positron emission tomography in the preoperative staging of thoracic oesophageal and gastro-oesophageal junction cancer: a prospective study.
    Katsoulis IE; Wong WL; Mattheou AK; Damani N; Chambers J; Livingstone JI
    Int J Surg; 2007 Dec; 5(6):399-403. PubMed ID: 17631431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-body FDG positron emission tomographic imaging for staging esophageal cancer comparison with computed tomography.
    Meltzer CC; Luketich JD; Friedman D; Charron M; Strollo D; Meehan M; Urso GK; Dachille MA; Townsend DW
    Clin Nucl Med; 2000 Nov; 25(11):882-7. PubMed ID: 11079584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma.
    Swisher SG; Erasmus J; Maish M; Correa AM; Macapinlac H; Ajani JA; Cox JD; Komaki RR; Hong D; Lee HK; Putnam JB; Rice DC; Smythe WR; Thai L; Vaporciyan AA; Walsh GL; Wu TT; Roth JA
    Cancer; 2004 Oct; 101(8):1776-85. PubMed ID: 15386332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the introduction of integrated PET-CT into the preoperative staging pathway of patients with potentially operable oesophageal carcinoma.
    Salahudeen HM; Balan A; Naik K; Mirsadraee S; Scarsbrook AF
    Clin Radiol; 2008 Jul; 63(7):765-73. PubMed ID: 18555034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma.
    Kato H; Miyazaki T; Nakajima M; Takita J; Kimura H; Faried A; Sohda M; Fukai Y; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Kuwano H; Oriuchi N; Endo K
    Cancer; 2005 Jan; 103(1):148-56. PubMed ID: 15558794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The utility of FDG-PET for detecting multiple primary cancers in hypopharyngeal cancer patients.
    Kaida H; Ishibashi M; Kurata S; Uchiyama Y; Tanaka N; Abe T; Kobayashi M; Kaibara H; Uchida M; Nakashima T; Fujita H; Hayabuchi N
    Nuklearmedizin; 2009; 48(5):179-84. PubMed ID: 19639163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography.
    Flanagan FL; Dehdashti F; Siegel BA; Trask DD; Sundaresan SR; Patterson GA; Cooper JD
    AJR Am J Roentgenol; 1997 Feb; 168(2):417-24. PubMed ID: 9016218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Routine positron emission tomography does not alter nodal staging in patients undergoing EUS-guided FNA for esophageal cancer.
    Keswani RN; Early DS; Edmundowicz SA; Meyers BF; Sharma A; Govindan R; Chen J; Kohlmeier C; Azar RR
    Gastrointest Endosc; 2009 Jun; 69(7):1210-7. PubMed ID: 19012886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of positron emission tomography in the (re-)staging of oesophageal cancer.
    Westerterp M; Van Westreenen HL; Sloof GW; Plukker JT; Van Lanschot JJ
    Scand J Gastroenterol Suppl; 2006; (243):116-22. PubMed ID: 16782630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role?
    Cuellar SL; Carter BW; Macapinlac HA; Ajani JA; Komaki R; Welsh JW; Lee JH; Swisher SG; Correa AM; Erasmus JJ; Hofstetter WL
    J Thorac Oncol; 2014 Aug; 9(8):1202-6. PubMed ID: 25157774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.